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We tracked pathogenic myelin basic protein-specific CD4
 
 
 
 effector T cells in early central 
nervous system (CNS) lesions of experimental autoimmune encephalomyelitis (EAE) by 
combining two-photon imaging and fluorescence video microscopy. We made two key 
observations: (a) the majority of the cells (65%) moved fast (maximal speed 25 
 
 
 
m/min) 
and apparently nondirected through the compact tissue; and (b) a second group of effector 
T cells (35%) appeared tethered to a fixed point. Polarization of T cell receptor and 
adhesion molecules (lymphocyte function-associated antigen 1) towards this fixed point 
suggests the formation of immune synapses. Nonpathogenic, ovalbumin-specific T cells were 
not tethered in the CNS and did not form synapse-like contacts, but moved through the 
tissue. After intrathecal injection of antigen, 40% of ovalbumin-specific T cells became 
tethered. Conversely, injection of anti–major histocompatibility complex class II antibodies 
profoundly reduced the number of stationary pathogenic T cells within the CNS (to 15%). 
We propose that rapid penetration of the CNS parenchyma by numerous autoimmune 
effector T cells along with multiple autoantigen-presentation events are responsible for the 
fulminate development of clinical EAE.
 
Organ-specific autoimmune diseases are trig-
gered commonly by tissue-specific autoaggressive
T lymphocytes. These cells persist as normal
components in the healthy immune repertoire.
Only upon activation in the peripheral organ-
ism they reach their target organ via the blood-
stream where they mount an attack against the
local milieu, the starting point of a pathogenic
inflammatory reaction (1, 2). This scenario essen-
tially rests on observations that were made in a
rodent model of brain autoimmunity, experi-
mental autoimmune encephalomyelitis (EAE),
but also has been verified in other models,
such as autoimmune diabetes (3, 4).
EAE can be mediated in adult inbred rats
or mice by parenteral transfers of freshly activated
brain-specific CD4
 
 
 
 T cells. These encephalito-
genic T cells enter the central nervous system
(CNS) in two distinct waves. The first wave
reaches the CNS within the first few hours
following transfer, with just a few activated
cells passing through the tight endothelial
blood–brain barrier. However, these “pioneer
cells” do not cause any immediate clinical or
histological changes, but rather seem to pre-
pare the CNS tissues for a second, much more
massive wave of invading effector cells, which
comes after a prodromal lag period of 3–4 d (5,
6). Then, within hours, the CNS tissue is infil-
trated by millions of immune cells and mac-
rophages, a process that coincides with the abrupt
onset of neurological disease. We showed before
that the inflammatory cell populations that enter
the CNS at the onset of EAE are dominated by
autoimmune effector cells (7). Using biological
fluorescent labels, we found that in these initial
stages of CNS invasion, 
 
 
 
90% of all infiltrating
CD4
 
 
 
 T cells are unequivocal effector lym-
phocytes. How can so many autoimmune T
cells pass into a compact tissue, such as the
CNS, within such a short period? How do the
lymphocytes move through the parenchyma,
and with which local cells do they interact?
We have traced the behavior of encephalito-
genic effector T cells directly during the critical
early phases of EAE development by real-time
imaging approaches. We observed two distinct
types of T cell behavior: (a) a major proportion
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of the autoimmune T cells meanders rapidly through the
CNS tissue, and (b) a minor, although substantial, part of the
cells seems to become attached to a fixed point and spins viv-
idly around this pivot. We show that the attached, but not
the migrant T cells target T cell receptor and cell adhesion
molecules to the pivots, reminiscent of immune synapses.
 
RESULTS
Motility of encephalitogenic T cells in early EAE lesions
 
We induced EAE in Lewis rats by transferring myelin basic
protein
 
 
 
(MBP)-specific T cells (T
 
MBP-GFP
 
) which had been en-
gineered retrovirally to express GFP (8). As expected, the flu-
orescent effector T cells invaded the CNS massively at the on-
set of clinical disease, 3–4 d after T cell transfer. We studied
the behavior of these autoreactive T cells during this early
clinical phase of EAE in live spinal cord slices by combining
two-photon imaging and fluorescence videorecording.
We found large numbers of fluorescent effector T cells
throughout the CNS tissue. The cells were distributed evenly
within the white and gray matter and infiltrated deep into the
parenchyma (Fig. 1 A). Their locomotion paths were recorded
first using three-dimensional time-lapse microscopy. All viable
T cells (
 
 
 
90; Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20050011/DC1) vividly changed their body
shape (Video 1, available at http://www.jem.org/cgi/content/
full/jem.20050011/DC1), but they differed radically in loco-
motor behavior; most of the cells (65%) cruised through the
nervous tissue at high velocity (“motile” cells; Fig. 2, A and D;
Video 2, available at http://www.jem.org/cgi/content/full/
jem.20050011/DC1). At the same time, a minor set of cells
(35%) remained confined to a narrow area (“stationary” cells;
Fig. 2, B and D; Video 3, available at http://www.jem.org/
cgi/content/full/jem.20050011/DC1).
 
Locomotion characteristics of autoreactive T cells 
within the CNS
 
Chemokines are the main agents that control the formation
of EAE infiltrates, and chemokine gradients should guide in-
flammatory cells into and through the CNS tissues. There-
fore, it came as a surprise that the motile T cells did not cross
the CNS parenchyma with any order but seemed to cruise
through the tissue at random. Analysis of migratory trajecto-
ries showed that the vector sum of their directions and
lengths was close to zero (Fig. 3 A). Stationary T cells
seemed to be trapped in their location, but within this con-
fine they were remarkably agitated. Apparently fixed to one
particular anchor point, they changed their shapes rapidly by
extending and retracting protrusions (Fig. 2 B). Mean square
displacement plots confirmed the morphological observa-
tions: they distinguished two populations, a population with
constant displacement over time (i.e., freely moving motile
T cells) and a population of cells that reached a low plateau
(
 
 
 
r
 
2
 
 
 
 
 
 
 
 6.75, stationary cells; Fig. 3 C).
The motile cells traveled with an average velocity of 6
 
 
 
m/min; some reached maximal values of 25 
 
 
 
m/min (Fig.
4 A). However, this locomotion was not constant, but pro-
ceeded in a “stop and go” mode. Phases of rapid progression
alternated with periods of slow movement or no motion
(Fig. 4 C). Depending on their speed, the T cells seemed to
change shape. During fast locomotion, many cells had a po-
larized shape with a broad leading edge followed by a slim
tail—a uropod. After deceleration, which often was coinci-
dent with a change of direction, the T cells assumed an
amoeboid shape with pseudopodia which extended in vari-
ous directions (Video 4, available at http://www.jem.org/
cgi/content/full/jem.20050011/DC1). The duration of fast
and slow phases was similar (moving phase: 1.4 
 
 
 
 0.7 min,
resting phase: 1 
 
 
 
 0.6 min; Fig. 4 C). The locomotor be-
havior of encephalitogenic T cells in the CNS lesion is rem-
iniscent of T cells that migrate through peripheral lymphoid
organs with comparable velocities, and along random migra-
tion tracks (9).
It is tempting to speculate that migratory encephalitoge-
nic T cells scan the target tissue in search of “their” autoanti-
gen as presented by local APCs, and that their stationary
counterparts have found the autoantigen (i.e., they are in the
Figure 1. Distribution of TMBP-GFP and TOVA-GFP cells in early EAE 
lesions. (A) Confocal microscopy showing TMBP-GFP cells (green) in spinal cord 
lesions 4 days after transfer. Vessels are visualized by dextran–Texas red in-
jection. (B) Distribution of TOVA-GFP cells in EAE lesions 4 d after cotransfer with 
nonlabeled TMBP cells. CNS parenchyma is labeled by Topro. Bars, 10  m. 
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process of recognition). This hypothesis makes several pre-
dictions: (a) only T cells with receptors for CNS autoanti-
gens should enter a stationary phase; T cells specific for an
antigen absent from the CNS should be permanently mi-
grant; (b) the stationary MBP-reactive T cells should form
structural features that reflect antigen recognition (e.g., im-
mune synapse-like TCR polarizations); and (c) MBP-spe-
cific T cells, but not nonspecific T cells, should be reacti-
vated within the CNS.
 
Motility of nonencephalitogenic T cells in EAE lesions
 
We studied first the behavior of CNS-nonspecific T cells.
These do not enter the CNS spontaneously in substantial
numbers (7). Only after local application of antigen do these
cells accumulate in the CNS (10). However, also without ar-
tificial manipulations, CNS-nonspecific T cells can be lured
into the CNS under two conditions: the CNS must be
primed to become receptive for large number of T cells.
Priming is achieved in a 3- to 4-d prodromal period between
transfer of encephalitogenic effector T cells and onset of clin-
ical EAE (7, 11). In addition, the nonspecific T cells must as-
sume a functional profile (“migratory phenotype”) that en-
ables them to go through a primed blood–brain barrier (7).
Both conditions are fulfilled by cotransferring GFP-express-
ing OVA-specific T cells (T
 
OVA-GFP
 
 cells) as reporters along
with nonlabeled MBP-specific T cells, which prime the CNS
(12). Such green OVA-specific T cells entered the CNS on
day 4 after transfer, and distributed through the tissue just like
their encephalitogenic counterparts (Fig. 1 B; reference 7).
Also similar to MBP-specific T cells, the migratory tracks of
T
 
OVA-GFP
 
 cells within CNS lesions were random (Fig. 3 B),
and their locomotion was saltatory (moving phase: 1.4 
 
 
 
 1
min; resting phase: 1.2 
 
 
 
 1 min; Fig. 4, B and D). However,
T
 
OVA-GFP
 
 cells differed strikingly from MBP-specific T cells
by their high proportion of motile cells (95 
 
 
 
 1%; Fig. 2, C
and D; Video 5, available at http://www.jem.org/cgi/con-
tent/full/jem.20050011/DC1),
 
 
 
as
 
 
 
reflected in their higher
average velocity (8 
 
 
 
m/min of the OVA-specific T cells ver-
sus 4 
 
 
 
m/min of the MBP-specific T cells) and the mean
square displacement plots (Figs. 3 D and 4 B). The difference
in motility patterns within the CNS between encephalitoge-
 
Figure 2. Motility of auto and control antigen-specific T cells in 
EAE lesions. 
 
(A, B)
 
 
 
Two-photon live microscopy of T
 
MBP-GFP
 
 cells in acute 
spinal cord slices. Two types of T cell movements are observed within CNS 
lesions: “motile” (A) and “stationary” (B) T
 
MBP-GFP
 
 cells. Numbers indicate 
time after start of the analysis (minutes). Dotted lines indicate the trajec-
tories and the cell shape of the preceding pictures. Arrows point to the 
tracked cells. Representative cells of 10 videos from four independent 
experiments. Bars, 10 
 
 
 
m. (C)
 
 
 
Locomotion of T
 
OVA-GFP
 
 cells in living spinal 
cord slices analyzed by two-photon analysis (4 d after cotransfer of T
 
MBP
 
 
cells and T
 
OVA-GFP
 
 cells). A representative cell of 6 videos from three inde-
pendent experiments is shown. Bar, 10 
 
 
 
m. (D) Proportion of motile 
versus stationary MBP- (T
 
MBP
 
 cells) and OVA- (T
 
OVA
 
 cells) specific T cells in 
living CNS slices (video microscopy). Motile T cells were defined as cells 
which migrated 
 
 
 
10 
 
 
 
m in 10 min. Cells were grouped as stationary if 
they moved 
 
 
 
10 
 
 
 
m in 10 min. T
 
MBP
 
 cells: means 
 
 
 
 SD from 6 indepen-
dent experiments including 
 
 
 
700 cells from 11 videos. T
 
OVA
 
 cells:
means 
 
 
 
 SD of 187 cells from 4 videos and three independent experi-
ments. Student’s 
 
t
 
 test, *P 
 
 
 
 0.001. 
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Figure 3. Encephalitogenic, but not control-antigen specific, T
 
GFP
 
 
cells show confined motility within the CNS. 
 
(A, B)
 
 
 
Random walk of 
T
 
GFP
 
 cells within the CNS. (A) Superimposed trajectories of T
 
MBP-GFP
 
 cells 
(each line represents one cell) over a 10-min time span analyzed by video 
microscopy. 
 
 
 
: trajectory vector calculated from the sum of all cell trajec-
tory vectors divided by the number of cells (
 
n
 
 
 
 
 
 200 cells). Top plot: 
trajectories of stationary and motile T
 
MBP-GFP
 
 cells. Bottom left plot: motile 
T cells; bottom right plot: stationary T cells. 50 trajectories from 4 inde-
pendent experiments. (B) Trajectories of T
 
OVA GFP
 
 cells in the CNS. 50 trajec-
tories from 3 independent experiments. (C, D) Mean square displacements  
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nic and control antigen-specific T cells could not be attrib-
uted to intrinsic properties of the cells. The maximal velocity
of OVA- and MBP-specific T cells in the CNS was identical
(Fig. 4, A and B, and Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20050011/DC1).
 
T cell motility within the CNS is dependent on the presence 
of antigen and MHC class II
 
T
 
OVA
 
 cells became stationary as soon as OVA was presented
within the CNS. At the peak of their invasion into the
CNS—4 d after coinjection with T
 
MBP
 
 cells—soluble OVA
or control antigen was applied intrathecally into the cisterna
magna. After an additional 3 h, the motility of T
 
OVA-GFP
 
 cells
was analyzed in slices. In tissue treated with OVA, but not
with control antigen, more than one third of the T
 
OVA-GFP
 
cells (36 
 
 
 
 11%) had become stationary (Fig. 5). Conversely,
we used antibodies against MHC class II to manipulate mi-
gration of T
 
GFP
 
 cells. Intrathecal infusion of anti–MHC class
II antibodies decreased the proportion of stationary T
 
MBP-GFP
 
cells (3 h after antibody injection) by 50% and of stationary
T
 
OVA-GFP
 
 cells by 30% after coinjection with OVA (Fig. 5).
 
Synapse-like structures of encephalitogenic T cells at 
their fix point
 
If stationary T cells are involved in a process of antigen rec-
ognition, they should form specialized contacts with putative
APCs—“immune synapses” (13–15). As observed in cell
culture or immune organs, such contacts could be transient
or long-lasting, but they should entail polarized condensa-
tion of T cell receptors at the intercellular contact site. We
analyzed living and fixed spinal cord tissue 4 d after transfer
of T
 
MBP-GFP
 
 cells using antibodies to TCR and LFA-1
epitopes, both essential components of immune synapses
(Fig. 6). An unequivocally polarized pattern of TCR/LFA-1
was found in 27% (
 
 
 
 11%) of T
 
MBP-GFP
 
 cells, whereas 73%
(
 
 
 
 11%) displayed an even distribution. In three-dimen-
sional reconstructions these “synapse-like” TCR/LFA-1 po-
larizations displayed a more dispersed pattern instead of the
“classic” concentric, circularized compartmentalization of
the molecules (Fig. 6, A–C, and Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20050011/DC1). Nota-
bly, TCR polarizations of the autoreactive effector T cells
regularly occurred at the contact zone with MHC class II
 
 
 
cells (Fig. 6 D). To test if T cell motility correlated with
TCR/LFA-1 distribution pattern, we analyzed immunohis-
tochemically labeled living spinal cord slices (Fig. 6 E; Vid-
eos 6 and 7, available at http://www.jem.org/cgi/content/
full/jem.20050011/DC1). Importantly, the antibody label
did not alter the motility pattern of the cells substantially.
The vast majority (97% 
 
 
 
 6%) of cells, which initially dis-
played a polarized TCR/LFA-1 formation, were stationary.
Polarization of TCR/LFA-1 was localized at the fixed pole
of the stationary cells (Fig. 6 E, Videos 6 and 7). However,
35% 
 
 
 
 7% of cells with an evenly distributed TCR/LFA-1
staining pattern also were stationary; this indicated that po-
larization of TCR/LFA-1 is highly predictive but is not re-
quired for cells to become stationary. T
 
OVA-GFP
 
 cells that
were recruited to the CNS after cotransfer with MBP-spe-
cific T cells did not show a polarized distribution pattern of
TCR/LFA-1 (
 
 
 
3% 
 
 
 
 2%).
 
DISCUSSION
 
This is the first life imaging study of autoantigen-specific
CD4
 
 
 
 effector T cells in developing EAE lesions. Our work
was prompted by the recent discovery that the inflammatory
immune infiltrates are initiated by a mass invasion of effector
T cells into the CNS parenchyma (7). We used optical imag-
ing approaches to analyze the behavior of intraparenchymal
autoimmune T cells and we made several unexpected obser-
vations. The effector cells did not ooze into the compact
CNS tissue but moved with high speed and with a peculiar
locomotion pattern. Furthermore, a surprisingly high per-
centage (
 
 
 
30%) of the autoimmune effector T cells were in
the process of antigen recognition. These cells were spinning
around fixed points and forming long-lasting, synapse-like
contacts with MHC class II–expressing cells.
We used two well-established live imaging techniques—
two-photon microscopy and fluorescence video micros-
copy—to track the effector T cells in EAE lesions. These
techniques complement each other and lead to equivalent
results (Table S1, available at http://www.jem.org/cgi/
content/full/jem.20050011/DC1). In particular, the pro-
portion of stationary and motile cells and the calculated cell
velocities were comparable. Although phototoxicity and
photo-bleaching set serious limitations to conventional
video microscopy, within the observation period of 1 h we
did not observe such substantial effects. Video microscopy
allowed recording of large observation fields with fast acqui-
sition rates; however, as expected, it was limited to lower
penetration depths (
 
 
 
50 
 
 
 
m) than two-photon microscopy
(100–150 
 
 
 
m). Again, this limitation did not affect the re-
sults, which indicated that T cells close to the slice surface
move similarly to T cells that are deep within the tissue.
How can effector T cells move through compact CNS
tissue as fast as through “fluid” lymphoid tissues? Which
driving forces push the cells forward, and which mechanisms
 
of T
 
GFP
 
 cells plotted against time. (C) Representative plots for a motile 
(circles) and a stationary (squares) T
 
MBP-GFP
 
 cell are shown. The diffusion 
coefficient of D 
 
 
 
 5.72 
 
 
 
m/min of the curve and the cell velocity of 
V 
 
 
 
 3.31 
 
 
 
m/min indicate free movement of the motile cell. The motility 
of the stationary cell is strongly confined, as reflected by the plateau at 
r
 
2
 
 
 
 
 
 6.75. Bar diagrams: velocities and diffusion coefficients of 50 motile 
T cells, and r
 
2
 
 values of 50 stationary cells. Mean square displacements 
were calculated from 21,198 displacement steps. (D) Mean square dis-
placements of T
 
OVA-GFP
 
 cells within the CNS. A representative plot for a 
T
 
OVA-GFP
 
 cell shows nonrestrained motility, indicated by a diffusion coefficient 
of D 
 
 
 
 11.32 
 
 
 
m/min and a cell velocity of V 
 
 
 
 3.54 
 
 
 
m/min. Bar dia-
grams: velocities and diffusion coefficients of 50 TOVA-GFP cells. 9,347 time 
points were analyzed for evaluation of mean square displacements.ENCEPHALITOGENIC EFFECTOR T CELLS IN AUTOIMMUNE CNS LESIONS | Kawakami et al. 1810
clear their way through the parenchyma? It must be consid-
ered that we studied living spinal cord tissue explants. Dis-
connection from the blood stream may have influenced mi-
gratory behaviors. Two facts argue against this possibility;
first, the CNS parenchyma is separated from blood flow by a
dense endothelial blood–brain barrier which does not permit
free diffusion of blood-borne cells and molecules. Second,
even in lymphoid organs with their porous vasculature, no
gross differences of lymphocyte migration have been noted
between organs that were studied in situ or those that were
Figure 4. Movement pattern of TGFP cells within the CNS. (A, B) Velocity 
of TGFP cells in EAE lesions analyzed by fluorescence video microscopy. 
(A) TMBP-GFP cells were tracked in acute spinal cord slices 4 d after transfer, 
and the locomotion speed of motile (top histogram) and stationary (bottom 
histogram) cells was calculated. Instantaneous T cell velocities of 236 cells 
(160 motile and 76 stationary cells) determined at 10-s intervals up to 
10 min (4,616 time points) are shown. Average velocity (Av) is indicated. 
AV mot: AV of motile TMBP-GFP cells, AV stat: AV of stationary TMBP-GFP cells, AV tot: AV 
of all analyzed TMBP-GFP cells. (B) Instantaneous velocities of TOVA-GFP cells in 
the CNS. 188 cells were analyzed every 30 sec up to 10 min (3,375 time 
points). (C, D) “Stop and go” motility mode of TGFP cells. (C) TMBP-GFP cells 
displayed characteristic transitions from moving to resting phases and 
vice versa on their way through the CNS tissue (determined by the velocity 
of the cells over time). Resting phases were defined as  5  m/min, and 
moving phases were defined as  5  m/min. The duration of these phases 
is indicated within the graph. Top graph: motile TMBP-GFP cells; bottom 
graph: stationary TMBP-GFP cells. Six representative cells out of 236 cells are 
shown. (D) Moving pattern of TOVA-GFP cells within the CNS. Three represen-
tative cells out of 188 cells are shown. Analysis by fluorescence video 
microscopy.JEM VOL. 201, June 6, 2005 1811
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explanted in culture (16). The random tracks of fast migrat-
ing T cells argue against long-distance chemotactic gradients,
but they do not rule out local chemotaxis via soluble signals
that are secreted by the cells which form the local milieus. It
is known that many CNS cells, glia, and even neurons pro-
duce chemokines, in particular following proinflammatory
induction. Alternatively, contact-dependent locomotor sig-
nals (“haptotaxis”) may play a role. The fast opening of mi-
gratory tracks through compact tissue is another mystery.
The CNS parenchyma is a compact tissue which is com-
posed of myelinated axons embedded in glia cells, and these
cells are interconnected by extracellular matrix to form the
“perineuronal net” (17). This makes it difficult to imagine
that mere mechanical force opens the way. There may be
additional, positively acting factors at work, including pro-
teolytic enzymes. In fact, recent screening studies of gene
expression profiles by intralesional effector T cells using mi-
croarray approaches, demonstrated up-regulation of broad
panels of proteases (unpublished data).
We interpret the data of this study to suggest that the im-
mobilized MBP-specific T cells within EAE lesions are in
the process of antigen recognition and become reactivated.
Activation of encephalitogenic T cells has been documented
Figure 5. T cell motility depends on the presence of antigen and 
MHC class II. TOVA-GFP cells become stationary after intrathecal OVA injec-
tion. Live imaging of acute spinal cord slices 4 d after cotransfer of TMBP 
and TOVA-GFP cells. Left five bars: proportion of stationary TOVA-GFP cells with-
out manipulation (white bar) or 3 h after intrathecal injection of the con-
trol antigen BSA (cont. Ag), OVA, OVA plus isotype Ig control (OVA   cont. 
Ab), or OVA plus anti-MHC class II antibody (OVA   MHC II). Means   SD 
of 412 cells from eight videos and five independent experiments. *P   0.02; 
**P   0.002. Right three bars: blocking anti-MHC class II antibody reduces 
the number of stationary TMBP-GFP cells in the CNS. Proportion of stationary 
TMBP-GFP cells in spinal cord slices 3 h after intrathecal injection of anti-
MHC class II antibodies (MHC II, black bar). No manipulation (intact) or 
injection of isotype control antibody (cont. Ab) served as controls.
Means   SD of 320 analyzed cells. Video recording of six videos of
three independent experiments (P   0.001). Statistical significances
were evaluated using Student’s t test.
Figure 6. Immune synapses-like membrane structures in the CNS. 
(A) Polarization of TCR/LFA-1 in TMBP-GFP cells 4 d after transfer in spinal cord 
slices. Confocal imaging, immunostaining with TCR/LFA-1. GFP (green), LFA-1 
(red), TCR (blue). TMBP-GFP cells with polarized (closed arrow) and evenly dis-
tributed (open arrow) TCR/LFA-1 pattern. (B) Three-dimensional reconstruc-
tion of the synapse-like–forming TMBP-GFP cell (indicated cell from Fig. 6 A). 
(C) Contact plane of a TMBP-GFP cell with synapse-like TCR/LFA-1 polarization 
(arrow). (D) TMBP-GFP cell (green) contacting a MHC class II  cell (red). Note the 
polarization of TCR (blue) at the contact point of the cells. (E) TMBP-GFP cells 
that form synapse-like TCR/LFA-1 polarizations are “stationary.” Fluorescence 
video microscopy of living spinal cord tissue 4 d after transfer stained with 
anti-TCR/LFA-1 antibodies. Numbers indicate the time points of image acqui-
sition. Overlay of GFP (green), TCR (red), and LFA1 (blue) is shown. Bars, 10  m.ENCEPHALITOGENIC EFFECTOR T CELLS IN AUTOIMMUNE CNS LESIONS | Kawakami et al. 1812
in situ and ex vivo (7). The ultimate outcome of this reacti-
vation process (T cell proliferation and activation-induced
cell death) has not been addressed by our present work (18,
19). However, our finding that OVA-specific T cells that are
recruited to the CNS are not locally reactivated but show
similar apoptosis rates (Fig. S1), may favor an environmental,
rather than reactivation-related proapoptotic mechanism.
Previous reports characterized the initial contacts be-
tween naive T cells and APCs as multiple and short-lived
(20). Later in the antigen-priming process, longer-lasting
contacts were observed. Interestingly, there were no gross
differences between the behavior of naive CD4  and CD8 
T cells (21). In the EAE lesions that were studied here, the
contacts between T cells and stroma were long-lasting and
solid. Compared with OVA-specific T cells, motile MBP-
specific T cells moved more slowly (Figs. 3 and 5). In the
presence of antigen, however, OVA-specific T cells reduced
their velocity and assumed the behavior of motile MBP-spe-
cific T cells (Fig. S2). Whether this deceleration reflects for-
mation of multiple, antigen-dependent ephemeral contacts
of effector cells and APCs or is due to a general reduction of
velocity remains to be established.
Although it is possible that early, ephemeral contacts re-
mained undetected for technical reasons, our model differs
substantially from the systems that were used by previous in-
vestigators. The effector T cells that were used in our studies
were antigen-experienced CD4  T line cells which had
been activated in vitro before transfer, and had undergone a
complex rearrangement of their gene expression pattern on
the way to the CNS and within the target tissue. Further,
most potential target cells in inflammatory spinal cord were
facultative, not constitutive APCs, which required proin-
flammatory signals to become capable of processing and pre-
senting protein (auto-)antigens, and they are virtually ubiq-
uitous within the CNS tissues.
A recent report described synapse-like contacts between
GFP-transgenic CD8  T cells with lymphocytic choriomen-
ingitis virus specific receptors and infected CNS cells in fixed
tissue samples (22). Reflecting the viral expression pattern,
the T cells were concentrated in the leptomeninges and the
choroid plexus, but rarely penetrated the brain parenchyma.
Our study demonstrates countless synapse-like contacts
within the CNS tissue. Each of these contacts may trigger
profuse secretion of cytokines, chemokines, and other solu-
ble mediators.
Our findings may help to explain the abrupt development
of clinical EAE after a symptom-free prodromal period. We
reported previously that the CNS tissues are invaded by mil-
lions of autoimmune T cells during the initial phases of EAE
(7). A large proportion of these cells becomes activated there,
and the level of reactivation dictates the clinical severity of
the ensuing EAE (23). Our live imaging studies show, for the
first time, the dynamic nature of effector cell invasion. En-
cephalitogenic effector T cells invade into all areas of the
CNS tissue (Table S2, available at http://www.jem.org/cgi/
content/full/jem.20050011/DC1). The affected tissue is zig-
zagged permanently by a major part of these effector cells,
whereas another, somewhat minor part of the cells gets ar-
rested and forms contacts with local MHC class II  APCs
(Table S2). Both processes may be required to set the stage
for the development of clinical EAE. Penetration of the com-
pact, highly vulnerable CNS tissue by millions of effector T
cells may break up organized structures via mere mechanical
force and/or enzymatic digestion. Disruption of the perineu-
ronal net, which stabilizes synapses in the adult brain, should
affect interneuronal communication directly and lead to neu-
rological deficiency. Our recent observation that CNS au-
toreactive T cells with low pathogenic potential intensively
infiltrate the CNS, but do not become highly activated (23),
may argue against T cell migration as a prevalent mechanism
in the acute inflammatory pathogenesis.
More important may be the effect of antigen recognition
by the infiltrated effector cells. Considering the amazing
density of immune synapse-like contacts between T cells and
target tissue, there should be a correspondingly high level of
T cell-derived proinflammatory mediators. We propose that
these mediators act directly on neuronal cells; indirectly by
activating local glial cells; and finally, by attracting and stim-
ulating blood-borne monocytes/macrophages.
These data are of relevance for the understanding of dis-
ease mechanisms in multiple sclerosis and other organ-spe-
cific autoimmune diseases. Furthermore, these findings may
open new targets for successful therapeutic strategies.
MATERIALS AND METHODS
Animals and antigens
Lewis rats were obtained from the animal breeding facilities of the Max-
Planck-Institute for Neurobiology and were kept under standardized condi-
tions. Antigen-specific T cell clones used in the study were specific for
guinea pig MBP and OVA. MBP was purified from guinea pig brains as de-
scribed (24). Hen egg OVA and BSA were obtained from Sigma-Aldrich.
All animal experiments were performed with the license of the Regierung
von Oberbayern (No: 209.1/211-2531-56/99).
Generation of T cells and EAE induction
MBP- and OVA-specific CD4  T cells that were engineered retrovirally to
express the marker gene EGFP were generated as described previously (8).
For EAE induction, 5   106 cells were injected intravenously into healthy
recipient rats. In coinjection experiments, 5   106 nonlabeled MBP-specific
T cells were transferred together with 10   106 GFP  OVA-specific T
cells. The animals were monitored daily by measuring weight and examin-
ing disease scores (8).
Acute spinal cord slices
Animals were killed under deep anesthesia and spinal cords were explanted.
Acute slices (thickness: 300  m) of spinal cords were prepared with a tissue
chopper (Mickle Laboratory Engineering) and immediately transferred into
ice cold artificial cerebral–spinal fluid buffer (ACSF: 1.25 mM NaH2PO4,
26 mM NaHCO3, 126 mM NaCl, 2.5 mM CaCl2, 2.5 mM KCl, 1 mM
MgCl2, 10 mM glucose, 1 mM pyruvate, 50  M glycine) oxygenized with
95% O2 5% CO2.
Live cell imaging
Two-photon system. Time-lapse two-photon laser-scanning microscopy
was used to produce time-lapse images of the movements of EGFP-positiveJEM VOL. 201, June 6, 2005 1813
ARTICLE
T cells in all three spatial dimensions. Spinal cord slices were placed in a
custom-made chamber maintained at 35 C and continuously superfused
with carbogenated ACSF (95% O2 5% CO2). The red excitation light (   
840 nm) from a 5 W Mira-Verdi laser system (Coherent) was routed
through a Fluoview 200 scanner (Olympus), a suitable dichroic mirror
(LOT Oriel), and a 40 , 1.2 numerical aperture (NA) water immersion
objective (Carl Zeiss Microimaging, Inc.) mounted on an inverted IX70
microscope (Olympus). The power of the excitation light could be adjusted
continuously by an acousto-optical modulator (Polytec); its average value at
the objective was set to 10–20 mW. The fluorescence was detected by an
external photomultiplier tube (R6357, Hamamatsu). Image acquisition and
online analysis was performed by Fluoview software (Olympus) and image
stacks were saved to disk for off-line analysis. The image resolution was 691
nm/pixel in x-y, with a field of view of 383   383  m2. A piezoelectrical
actuator (Physik Instrumente) was used to move the objective in the z-axis
( z   3  m) over a total depth of 60  m. Images were Kalman-averaged
over three frames. The stacks were acquired every 3 min or where indicated
every 30 s for 1 h. For the higher acquisition rates, the image was Kalman-
averaged over two frames and the field was reduced to 190   190  m2 in
the x-y direction and 30  m in depth.
Image analysis. Four-dimensional (x,y,z,t) image stacks were processed
and analyzed using the Imaris 4 software (Bitplane). Individual stacks were
subjected to a Gaussian spatial filter, rescaled, and baseline-subtracted. To
facilitate overview, the three-dimensional stacks were volume-rendered as
two-dimensional images; however, all image analysis was done by visual in-
spection of the individual image sections. Cell trajectories and cell velocity
were evaluated using the Imaris software.
For statistical evaluation of the respective movements, 21,198 mean
square displacement steps (of 50 stationary and motile MBP-specific T cells,
respectively) were analyzed for MBP-specific T cells and 9,347 steps were
analyzed for OVA-specific T cells. The distribution function for square dis-
placements was analyzed by applying the microscopic theory of diffusion,
according to Fick’s second law. All plots were fitted by using Origin soft-
ware (Microcal; reference 25). Mean square displacements were calculated
with the following formula: P(r2,t)   1 exp( r2/r1
2) where P   probabil-
ity, r   displacements, t   time, and r1   fitting parameter. Motile and sta-
tionary mean square displacement were fitted to y   4 • D • x   (v • x)2
and y   r2c • {1 A1 • exp[(-4 • A2 • D • x)/r2c]}, respectively, where
r2c   square of confined radius and A1 and A2 are fitting parameters.
Fluorescence video microscopy. Acute slices were prepared and treated
as described above. Time-lapse recordings were performed at an inverted mi-
croscope (Zeiss, Axiovert 200M) equipped with a 20 , 0.4 NA objective and
a 40 , 0.6 NA objective (Zeiss). Images were acquired using a Coolsnap-HQ
camera (Photometrics, Roper Scientific) in 30-s time intervals and analyzed
using MetaMorph (Visitron Systems) and Image J software (Freeware, pro-
vided by Wayne Rasband, National Institutes of Health, Bethesda, MD).
Intrathecal antigen and antibody applications
Stereotactic intrathecal injection was performed into the cisterna magna of
anesthetized rats (300 mg/kg chloralhydrate, Merck; reference 23). Anti-
gens (30  g of OVA or BSA as control antigen; Sigma-Aldrich) or antibod-
ies (30  g anti-MHC class II or isotype control antibody) were injected 3 h
before spinal cord preparation. For blocking experiments with intrathecal
OVA and MHC class II antibodies, 10  g OVA and 30  g anti-MHC class
II antibody/isotype control antibody were injected.
Fluorescence immunolabeling
Spinal cord slices were incubated for 30 min with anti-TCR (R73), anti–
LFA-1, or anti-MHC class II (OX-6) Mab (dilution 1:300) in PBS 5% FCS.
The antibodies were obtained from Becton Dickinson. After washing for 10
min in PBS 5% FCS, secondary staining was performed with Cy3-conju-
gated anti–mouse antiserum (dilution 1:1,000, Dianova). For double stain-
ing, biotin-conjugated anti-TCR antibody (diluted 1:300, Becton Dickin-
son) detected by cy5-conjugated streptavidine (dilution 1:1,000; Molecular
Probes) was used. All staining steps were performed at 4 C. The slices were
imaged under cooled conditions followed by time-lapse recordings after re-
warming to 35 C. Means   SD from four independent experiments, in-
cluding  400 cells, are shown.
For staining with annexin V and active caspase 3, TMBP-GFP or TOVA-GFP
cells were isolated from spinal cords 4 d after transfer as described (7). Allo-
phycocyanin-labeled annexin V was obtained from Becton Dickinson. Stain-
ing was performed according to the manufacturer’s recommended protocol.
Rabbit anti-active caspase 3 antiserum (clone AF835) was purchased from
R&D Systems. After isolation from spinal cords, T cells were fixed for 20 min
in 2% PFA. Blocking and permeabilization was performed with PBS 0.1%
Triton X-100 (Sigma-Aldrich) containing 5% FCS. Active caspase 3 anti-
serum (dilution 1:100) was incubated overnight at 4 C followed by detection
of specific binding with PE-labeled goat anti–rabbit antiserum (Dianova; dilu-
tion 1:500). Analysis was performed with FACSCalibur (Becton Dickinson).
Confocal analysis
Immunohistochemical staining with Topro (Molecular Probes) of spinal
cord sections after fixation with 4% paraformaldehyde was performed as de-
scribed previously (7). For visualization of blood vessels, Texas red labeled
dextran (Molecular Probes) was injected 0.5 h before preparation of spinal
cord slices and fluorescence analysis. Fluorescence staining was evaluated us-
ing confocal laser-scanning microscopy equipped with 40 , 1.25–0.75 NA
or 63 , 1.4–0.6 NA oil objectives (Leica).
Online supplemental material
Table S1 shows a comparative analysis of motility of encephalitogenic T
cells in EAE lesions analyzed by two-photon microscopy and fluorescence
video microscopy. Table S2 depicts the proportions of stationary and motile
encephalitogenic T cells in different areas of the inflamed CNS. Fig. S1
shows the apoptosis rate (annexin V, active caspase 3) of TMBP and TOVA
GFP cells in inflamed spinal cord lesions. Fig. S2 depicts the influence of
antigen on the velocity of motile nonencephalitogenic T cells in EAE le-
sions. Fig. S3 supplements Fig. 6 E. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20050011/DC1.
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